Omicron May Not Evade All Monoclonal Antibodies, Study Suggests

The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study.

Related Keywords

James Crowe ,Eli Lilly ,Astrazeneca ,Washington University ,Vanderbilt Vaccine Center ,Vanderbilt University Medical Centre ,Study Suggests ,Nature Medicine ,Vir Biotechnology ,Omicron Variant Of Coronavirus ,Levade ,Monoclonal Antibodies ,